SMOC Therapeutics
Natick, US · Founded 2017 · Delaware corporation
Founders & leadership
KS
Kevin SprottExecutive
HW
Hao WuNamed on SEC filing
Board
SL
Shjiang LuBoard director
YW
Yong WangBoard director
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 1 round · 2017
▶$7.5MraisedJan 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedJan 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin SprottExecutive Officer
- Shjiang LuDirector
- Hao WuExecutive Officer, Director
- Yong WangDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has SMOC Therapeutics raised?
- SMOC Therapeutics has disclosed $7.5M raised across 1 round.
- Where is SMOC Therapeutics headquartered?
- SMOC Therapeutics is headquartered in Natick, US.